Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. The company is developing a unique and proprietary Click-to-Release platform to enable selective release of anticancer drugs in the tumor microenvironment. This platform has a broad set of application areas (antidrug conjugates, radioligands, T cell engagers and cytokines), and has the potential to increase antitumor efficacy while lowering potential toxicity for patients.
Tagworks Pharmaceuticals raised a €60 million Series A financing co-led by Gilde Healthcare to further develop its differentiated click chemistry platform and bring drug candidates to the clinic.
More Tagworks news
Tagworks Pharmaceuticals announces $64 Million in Series A financing co-led by Gilde Healthcare
CVRx
US-based MedTech company focused on treatment of heart failure applying neurostimulation.

Proverum
Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity...

Big Health
UK-based digital therapy company focused on mental disorders.
